"Obviously the focus is to deliver quality care all the time, while delivering a positive patient experience and being financially prudent," said Mr. Lowe, who has led the organization since December 2014. The health-care system consists of two hospitals: Physicians Regional Pine Ridge and Physicians Regional Collier Boulevard, a multi-specialty ph
Absorbable nasal implants are used to treat nasal blockage or obstructions and allow better breathing and sleep to the patient. Nasal airway obstruction can be caused by several factors, including septal deviation, enlarged turbinates, and weakened upper and/or lower lateral nasal wall cartilage, which can lead to nasal valve collapse.
-Achaogen, Inc., a clinical-stage biopharmaceutical company developing novel antibacterials addressing multi-drug resistant gram-negative infections, today announced that they have achieved a strategic milestone in their ongoing efforts to develop an assay enabling therapeutic drug management of plazomicin. Achaogen is developing plazomicin for...
Actinium Pharmaceuticals, Inc., a biopharmaceutical company developing innovative targeted therapies for cancers lacking effective treatment options, announced today that the Company is attending the BMT Tandem Meetings, the combined annual meetings of the American Society of Blood and Marrow Transplantation and the Center for International Blood
-Aphios Corporation today announced that it is spinning-off Aphios Pharma to develop FDA- approved, cannabis-based drugs for treating highly unmet Central Nervous System disorders such as opioid addiction, epilepsy including childhood epilepsy and multiple sclerosis that are only partially and anecdotally addressed by medical marijuana.
In February, Harris Healthcare successfully implemented the initial Go Live phase with Arnot Health Ira Davenport Memorial Hospital ED. Harris Healthcare has a proven best in KLAS level EDIS and EHR integrated solution. Im pleased with the level of client support Harris Healthcare provided throughout the process.
BD, a leading global medical technology company, today announced that its BD Veritor System Flu A+ B, a digital immunoassay for the rapid detection of influenza, meets the new FDA performance requirements.i. With the new FDA requirements, i rapid flu tests, which are used by health care providers and laboratory personnel, must now attain a higher l
Webcast Available at http://www.BioCorRx.comAnaheim, CA 02/23/2017 BioCorRx Inc., a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today provided an update on the preclinical development of BICX101, a new sustained release injectable naltrexone product for the treatment of substance abuse addic
Biothera Pharmaceuticals, Inc. today announced that dosing has been initiated in a Phase 2 clinical trial evaluating Biothera s Imprime PGG in combination with the Merck anti-PD-1 therapy, KEYTRUDA , in patients with either advanced melanoma who have progressed on treatment with a checkpoint inhibitor therapy, or with TNBC whose disease has
LONDON, UK/ ACCESSWIRE/ February 23, 2017/ Active Wall St. blog coverage looks at the headline from Ocular Therapeutix, Inc. as the Company announced on February 22, 2017, that the Company's New Drug Application resubmission for DEXTENZA?, for the treatment of ocular pain occurring after ophthalmic surgery has been accepted as a filing for review
Cadila Healthcare has received approval from US Food& Drug Administration to initiate Phase II clinical studies of Saroglitazar Magnesium in patients suffering from Primary Biliary. Cadila Healthcare has received approval from US Food& Drug Administration to initiate Phase II clinical studies of Saroglitazar Magnesium in patients suffering from...
Toru Nishizawa, president and CEO of Canon Virginia said: The addition of medical device manufacturing extends Canons commitment, manufacturing expertise and established resources into the medical device industry. Ron Kurz, director of medical programme management said: We can provide individually tailored solutions to meet the unique needs of...
CCHN will primarily establish, build and maintain a network of providers to serve this patient-focused Medicaid health plan. CCHN has two classes of common stock: Class M Common Stock, which is held by the NCMS, and Class P Common Stock, which CCHN anticipates offering to physicians, nurse practitioners and physician assistants licensed to practice
The data were presented in a poster at the American Society of Clinical Oncology Society for Immunotherapy of Cancer Clinical Immuno-Oncology Symposium being held from February 23 25, 2017 in Orlando, Florida. The strong in-vivo preclinical data suggest that CBT-501 may have clinical benefit in a variety of tumor types, said Sanjeev Red
-Cellceutix Corporation,, a clinical stage biopharmaceutical company developing innovative therapies with dermatology, oncology, anti-inflammatory, and antibiotic applications, today announced progression of its ongoing Phase 2 clinical trial of Brilacidin to the third cohort for induction of remission of mild-to-moderate ulcerative colitis after..
Feb. 22 PEORIA Oversimplified campaign rhetoric about repealing and replacing the Affordable Care Act discounts the complexity of America's health care industry, U.S. Rep. As Congressional Republicans craft legislation to replace former President Barack Obama's legacy law, Bustos made a stop at a Peoria supportive living community to bring atte
Its release ends an almost decade-long monopoly by Iressa, developed by British multinational biopharmaceutical company AstraZeneca and introduced to China in 2005.. Yiruike was approved for marketing by China's State Food and Drug Administration after Iressa's patent protection expired in April 2016, Qilu sources said. The drug is a much-needed fi
As our elected "representative," Mr. Collins has a duty to listen to and interact with his constituents beyond his occasional one-sided form letter. Could Mr. Collins perhaps respect his constituents enough to understand that they have serious concerns about how their healthcare bills will be covered if the Affordable Care Act is gutted by his part
WASHINGTON, Feb. 23, 2017/ PRNewswire-USNewswire/ Nonprofit Consumers' Checkbook/ Center for the Study of Services is releasing the names of the surgeons who based on the organization's in-depth analyses have the nation's best and worst outcomes in major surgeries. These analyses look at how often surgeons' patients die in hospital or withi
This report studies sales of Ultrasound-Guided High- intensity Focused Ultrasound System in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering. Split by applications, this report focuses on sales, market share and growth rate of Ultrasound-Guided High- intensity Focused Ultrasound
Curemark, LLC announced today that the Blm Study, a Phase 3 clinical trial to evaluate the safety and efficacy of CM-AT in children aged 3-8 with Autism, is now enrolling at three new sites. Joan Fallon, founder and CEO of Curemark. "Making our clinical trial available to as many children across the United States as possible, is an important ste
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today reported top-line results from the pivotal Phase 3 SEAMLESS study in elderly patients aged 70 years or older with newly diagnosed acute myeloid le
According to a new market research report " Diagnostic Imaging Market by Product, MRI, Ultrasound, CT, Nuclear Imaging), Application (OB/GYN, MSK, Cardiology, Oncology), End User (Hospitals, Imaging Centers)- Global Forecast to 2021", published by MarketsandMarkets, the report studies the global market over the forecast period of 2016 to 2021. The
In Dr. Spykers accomplished career, he held positions as Senior Director of Drug Safety and Pharmacovigilance at Alexza Pharmaceuticals; Director, Pharmacokinetics and Pharmacodynamic Sciences, Genentech, where he established the clinical pharmacology unit; and Senior Medical Director, Clinical Risk Assessment and Coordination Department at Purdue.
Durdans Laboratory Services, the fully-fledged laboratory arm of the Joint Commission International approved Durdans Hospital, whilst retaining its traditional Test Panel recently made available novel tests to keep up with modern developments in Laboratory Medicine. Noteworthy are the' predictive tests' whose outcomes can be utilised to avert' futu